Currently there is a clear trend towards the establishment of virus-like particles (VLPs) as a powerful tool for vaccine development. VLPs are tunable nanoparticles that can be engineered to be used as platforms for multimeric display of foreign antigens. We have previously reported that VLPs derived from rabbit hemorrhagic disease virus (RHDV) constitute an excellent vaccine vector, capable of inducing specific protective immune responses against inserted heterologous T-cytotoxic and B-cell epitopes. Here, we evaluate the ability of chimeric RHDV VLPs to elicit immune response and protection against Foot-and-Mouth disease virus (FMDV), one of the most devastating livestock diseases. For this purpose, we generated a set of chimeric VLPs containing two FMDV-derived epitopes: a neutralizing B-cell epitope (VP1 (140–158)) and a T-cell epitope [3A (21–35)]. The epitopes were inserted joined or individually at two different locations within the RHDV capsid protein. The immunogenicity and protection potential of the chimeric VLPs were analyzed in the mouse and pig models. Herein we show that the RHDV engineered VLPs displaying FMDV-derived epitopes elicit a robust neutralizing immune response in mice and pigs, affording partial clinical protection against an FMDV challenge in pigs.
COVID-19 is the name of the acute respiratory disease caused by the new coronavirus SARS-CoV-2, a close relative of those that caused the severe outbreaks of SARS and MERS several years ago. Since first appearance on December of 2019, the COVID-19 pandemic has cause extremely high levels of mortality, morbidity, global economic breakdown, and the consequent human suffering. The main diagnostic test for the confirmation of symptomatic individuals is the detection of viral RNA by reverse transcriptase–quantitative real time PCR (RT-PCR). Additionally, serology techniques, such as ELISA are useful to measure the antibodies produced in humans after contact with the virus, as well as the direct presence of viral antigens. In this study we aim to assemble and evaluate four ELISA assays to measure the presence of IgG or IgM specific for the viral Spike protein in COVID-19 patients, using either the full recombinant SARS-CoV-2 Spike protein or the fragment corresponding to the receptor binding domain. As a control, we analyzed a group of pre-pandemic serum samples obtained before 2017. Strong reactivity was observed against both antigens. A few pre-pandemic samples displayed high OD values, suggesting the possibility of some cross reactivity. All four assays show very good repeatability, both intra- and inter-assay. Receiver operating characteristic analysis allowed the definition of cutoffs and evaluation of performance for each ELISA by estimation of the area under the curve. This performance parameter was high for all tests (AUC range: 0.98–0.99). Multiple comparisons between tests revealed no significant difference between each other (P values: 0.24–0.95). Our results show that both antigens are effective to detect both specific IgG and IgM antibodies, with high sensitivity (range 0.92–0.99), specificity (range 0.93–0.97) and congruence with the RT-PCR test (Cohen´s Kappa range 0.87–0.93). These assays will allow health authorities to have a new tool to estimate seroprevalence, in order to manage and improve the severe sanitary situation caused by this virus.
Foot and mouth disease is a highly contagious disease affecting cattle, sheep, and swine among other cloven-hoofed animals that imposes serious economic burden by its direct effects on farm productivity as well as on commerce of farmed produce. Vaccination using inactivated viral strains of the different serotypes is an effective protective measure, but has several drawbacks including a lack of cross protection and the perils associated with the large-scale growth of infectious virus. We have previously developed chimeric virus-like particles (VLPs) bearing an FMDV epitope which induced strong specific humoral responses in vaccinated pigs but conferred only partial protection against homologous challenge. While this and other FMD vaccines under development mostly rely on the induction of neutralizing responses, it is thought that induction of specific T-cell responses might improve both cross protective efficacy as well as duration of immunity. Therefore, we here describe the development of a recombinant adenovirus expressing the highly conserved nonstructural FMDV 3D protein as well as its capacity to induce specific T-cell responses in a murine model. We further describe the generation of an FMDV serotype C-specific chimeric VLP and analyze the immunogenicity of two different prime-boost strategies combining both elements in mice. This combination can effectively induce both humoral and cellular FMDV-specific responses eliciting high titers of ELISA and neutralizing antibodies anti-FMDV as well as a high frequency of IFNγ-secreting cells. These results provide the basis for further testing of this anti FMD vaccination strategy in cattle or pig, two of the most relevant natural host of this pathogen.
Background and Aim: The COVID-19 pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has raised concern regarding anthropozoonotic transmission to domestic animals, posing potential public and veterinary health risks. Latin America remains underrepresented in seroepidemiological assessments of such zoonotic spillover. This study aimed to detect anti-SARS-CoV-2 antibodies in domestic dogs and cats in Panama using a One Health surveillance framework. Materials and Methods: A cross-sectional serological survey was conducted between October 2022 and December 2023 across the metropolitan area of Panama City. Serum samples from 341 animals (198 dogs and 143 cats) were analyzed using a commercial double-antigen enzyme-linked immunosorbent assay to detect antibodies targeting the SARS-CoV-2 nucleocapsid protein. A historical panel of 100 pre-pandemic canine and feline samples was also tested. Demographic, clinical, and exposure data were collected through owner questionnaires, and statistical associations with seropositivity were assessed using univariate tests and binary logistic regression. Results: Seropositivity was detected in 12/341 animals (3.5%; 95% confidence interval: 1.96–6.11%), comprising 9 dogs (4.5%) and 3 cats (2.1%). In addition, 2/100 pre-pandemic canine samples (2.0%) tested positive. Most seropositive animals (75%) were reported to have lived in households with confirmed COVID-19 cases, although this variable was not statistically associated with seropositivity. Regression analysis identified ideal body condition as a significant predictor (p = 0.016), while sampling location and demographic variables were not significant. Conclusion: This study presents the first serological evidence of SARS-CoV-2 exposure in domestic pets in Panama. While low in prevalence, the findings underscore the relevance of community-based animal surveillance and reveal possible serological cross-reactivity with endemic canine coronaviruses. The data support the continued integration of domestic animal monitoring into One Health strategies to preempt zoonotic risks and improve pandemic preparedness. Keywords: cats, dogs, One Health, Panama, serosurveillance, Severe acute respiratory syndrome coronavirus 2, anthropozoonosis.
24 July 2025 in Journal of Alzheimer's Disease Reports
Background: Accumulating evidence implicates infectious pathogens as triggers of immune–inflammatory processes that contribute to neurodegeneration. Inflammation in both the brain and peripheral circulation is recognized as a critical factor in the development and progression of cognitive decline and neurodegenerative disorders, including Alzheimer's disease. Objective: This retrospective case-control study investigated the association between cognitive impairment and presence of serum antibodies to seven pathogens in older adults. Methods: One hundred sixty-five participants aged ≥ 65 years from the Panama Aging Research Initiative Health Disparities (PARI-HD) study were evaluated. Presence of IgG antibodies against Toxoplasma gondii , Herpes Simplex Virus Type 1 (HSV-1), Human Cytomegalovirus (HCMV), Helicobacter pylori, Chlamydia pneumoniae, Treponema pallidum , and Trypanosoma cruzi was measured. Participant demographics, inflammatory biomarkers and cognitive-functional factors were analyzed for associations with single/multiple pathogen-specific antibodies reactivity using multivariable regression models. Results: Only C. pneumoniae seropositivity was significantly different between cognitively unimpaired and impaired groups (p = 0.02) and increasing TNF-α levels were directly associated with C. pneumoniae seropositivity (OR = 2.08, CI 95% 1.0–4.1, p = 0.04). Additionally, cumulative exposure to infectious agents increased the likelihood of cognitive impairment (OR = 1.51, CI 95% 1.01–2.26, p = 0.04) and was associated with slower processing speed as measured by TMT A test (OR = 17.43, CI 95% 2.32–32.53, p = 0.02). Notably, the presence of C. pneumoniae in multiple pathogen interactions further raised the likelihood of cognitive impairment (OR = 4.07, CI 95% 1.24–13.36, p = 0.03). Conclusions: These results enhance our understanding of cognitive impairment in a Hispanic population and underscore the need for further studies on the role of C. pneumoniae and multi-pathogen infection in Alzheimer's disease.
Background: Studies on blood‐based biomarkers associated with age‐related cognitive impairment are key to improve intervention mechanisms and delay the expression of symptoms. The objective of this study was to assess the relationship between blood‐based biomarkers and mild cognitive impairment (MCI) and AD in a sample of elderly Panamanians enrolled from an outpatient geriatric service.Method: A descriptive, cross‐sectional, observational study was conducted. Participants were 84 Panamanians (controls, n=41; MCI=32; and AD=11). They were assessed with MMSE and Clock Test. Non‐fasting blood samples were collected to genotype for ApoE4 and to determine a blood‐based biomarker profile.Result: CRP levels among AD participants were significantly increased relative to MCI participants (p < 0.05). A2M levels in AD participants were significantly increased compared to normal controls (p < 0.05). SAA levels in AD participants were significantly increased when compared to MCI participants (p < 0.05).Conclusion: These results show that in the AD group CRP, A2M and SAA are significantly increased. The link between MCI and AD and inflammatory markers can produce an accurate tool that can aid in early diagnosis of AD.